Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1081 of 5804
-
Can a gentle massage and scent boost appetite in dementia?
Symptom relief ENROLLING_BY_INVITATIONFeeding difficulties are a common issue among individuals with dementia during moderate to advanced stages, particularly those in long-term care (LTC) facilities. Due to severe cognitive and communicative impairment, these residents often have a high dependency on feeding assista…
Phase: NA • Sponsor: National Cheng Kung University • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New combo aims to stop pain before it starts in breast cancer surgery
Prevention Not yet recruitingThe goal of this clinical trial is to is to compare the effectiveness of ultrasound-guided Pecs block with intravenous ketamine versus intravenous ketamine infusion alone in preventing Chronic Post-Surgical Pain (CPSP) in patients undergoing breast cancer surgery. The main questi…
Phase: NA • Sponsor: Aga Khan University • Aim: Prevention
Last updated Jun 27, 2026 09:06 UTC
-
Can your muscles predict a heart attack? new AI study aims to find out
Knowledge-focused Not yet recruitingThis study is designed as a prospective, single-center, observational cohort study (the SMART-SCD Study, full name: Skeletal Muscle Multi-omics Analysis and Risk Tailoring in Sudden Cardiac Death), which enrolls high-risk populations meeting the criteria for implantable cardiover…
Sponsor: China National Center for Cardiovascular Diseases • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Which drug stops joint damage best in early psoriatic arthritis?
Disease control Recruiting nowInvestigators hypothesize that TNFi is superior to SC MTX in preventing structural damage in early, treatment-naïve PsA, assessed using HR-pQCT. The study aims to ascertain: \- The effect of SC MTX and TNFi (adalimumab biosimilar) on erosion and enthesiophyte progression in earl…
Phase: PHASE4 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New drug gecacitinib tested for tough transplant complication
Disease control Not yet recruitingThis study aims to evaluate the safety and efficacy of Gecacitinib in patients with steroid-refractory/dependent active chronic graft versus host disease (cGVHD).
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Washing kidneys to stop hidden virus: new trial aims to make transplants safer
Disease control Not yet recruitingDonor organs often carry latent Cytomegalovirus (CMV) infection that may be transmitted to the recipient. The goal of this clinical trial is to determine the safety of SYN002 treatment during Ex-Vivo Organ Perfusion (EVOP) in clinical kidney transplantation. Donor kidneys will be…
Phase: EARLY_PHASE1 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New radiation combo aims to shrink sarcomas before surgery
Disease control Recruiting nowThe goal of this prospective, single-arm, phase II trial is to evaluate whether a preoperative regimen combining spatially fractionated radiation therapy (SFRT) with subsequent surgery can improve outcomes in patients with large (≥5 cm) limb/trunk soft tissue sarcoma (STS). Curre…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Can a zapping cap restore joy in depressed seniors?
Symptom relief Recruiting nowThis project focuses on clinical translational research into personalized transcranial alternating current stimulation (tACS) for treating anhedonia in late-life depression (LLD). Key components include: (1) Optimizing individualized tACS treatment parameters through randomized, …
Phase: NA • Sponsor: Jie Li • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
New kidney stone vacuum device aims to leave no fragment behind
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate the effectiveness and safety of Steerable Ureteroscopic Renal Evacuation (SURE) with the CVAC System versus other commonly used renal-stone interventions.
Sponsor: Calyxo, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New insulin system aims to simplify diabetes management
Disease control Recruiting nowThe purpose of this postmarket clinical investigation is to evaluate the levels of glycemic control, quality of life, and satisfaction, as well as the patient experience, and acute diabetes complication rates provided by the Omnipod 5 Automated Insulin Delivery System (referred t…
Sponsor: Insulet Corporation • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New combo tackles back pain from spine tumors
Symptom relief Recruiting nowThis study looks at how well a combination of treatments helps reduce pain in people with tumors in the middle and lower back (thoracic and lumbar spine). All participants receive the same treatment, which includes a procedure to stabilize the spine (kyphoplasty), radiofrequency …
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Tiny pacemaker, no wires: new trial tests LivIQ for heart rhythm control
Disease control Recruiting nowThe objective of this Investigational Device Exemption trial is to confirm the safety and performance of the LivIQ leadless pacemaker system, in patients with a Class I or II indication for ventricular pacing (VVI/VDD) according to applicable guidelines. An integrated atrioventri…
Phase: NA • Sponsor: Biotronik, Inc. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Can AI help keep your mind sharp? new trial tests digital coach for memory decline
Symptom relief ENROLLING_BY_INVITATIONMild cognitive impairment (MCI) is associated with increased risk of progression to dementia, highlighting the need for accessible interventions to support cognitive health. This randomized controlled trial will evaluate the safety and efficacy of a 12-month artificial intellige…
Phase: NA • Sponsor: Kaiser Permanente • Aim: Symptom relief
Last updated Jun 27, 2026 11:04 UTC
-
New targeted pill hopes to tackle tough leukemias
Disease control Recruiting nowThis is a single-center, open-label, investigator-initiated phase 1 study designed to evaluate the safety, pharmacokinetics (PK), and preliminary efficacy of the menin inhibitor BY002 in patients with relapsed or refractory acute leukemia. Eligible subjects include adult patients…
Phase: PHASE1 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New pain relief method could cut opioid use for war wounded
Symptom relief Not yet recruitingTo compare the effectiveness of continuous regional anaesthesia with standard pain management strategies for the treatment of acute pain in patients with war-related lower limb trauma.
Sponsor: Charitable Organisation Charitable Fund Superhumans (Co Cf Superhumans) • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Lab-Grown Mini-Tumors could predict best prostate cancer therapy
Knowledge-focused Recruiting nowFor men with an aggressive form of prostate cancer, finding the right and effective treatment right away is challenging. Many of these men face a high risk of cancer recurrence: about half experience a relapse after surgery, and more than a third after undergoing radiation therap…
Sponsor: Maastricht Radiation Oncology • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New Long-Acting HIV combo shot aims to simplify treatment
Disease control Not yet recruitingThe main objective of this national study is to evaluate the virological success of long-acting antiretroviral therapy combining cabotegravir and lenacapavir. The study involves patients who have been receiving this treatment for one year or those for whom the physician decides t…
Sponsor: Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Two-Drug combo may boost vision in diabetic eye disease
Disease control Not yet recruitingThis is a 12-month, prospective, randomized controlled, multi-center, open-label, superiority designed study. Treatment-Naïve DME patient with inflammatory biomarkers, who meet the inclusion and exclusion criteria, will be recruited. This study aims to provide the first direct c…
Phase: PHASE4 • Sponsor: Kun Liu • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New blood test aims to cut unnecessary prostate biopsies
Diagnosis Not yet recruitingThis prospective observational study will enroll men referred for prostate biopsy due to elevated PSA and/or abnormal digital rectal examination, with or without pre-biopsy MRI. Peripheral blood will be collected prior to biopsy for PROSTest analysis. Biopsy histopathology will s…
Sponsor: Wren Laboratories LLC • Aim: Diagnosis
Last updated Jun 27, 2026 09:11 UTC
-
Robot vs. visual training: which boosts stroke recovery more?
Symptom relief Recruiting nowStroke frequently leads to balance impairment and gait dysfunction, increasing fall risk and limiting functional independence. Technology-assisted rehabilitation approaches such as robot-assisted gait training and visual feedback balance training have been shown to improve balanc…
Phase: NA • Sponsor: Abant Izzet Baysal University • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC